Literature DB >> 19018217

Development and testing of the Alzheimer's Disease and Related Dementias Mood Scale.

Ruth M Tappen1, Christine L Williams.   

Abstract

BACKGROUND: Existing mood measures for individuals with Alzheimer's disease and related dementias (AD-RD) focus primarily on negative moods, including depression.
OBJECTIVE: The objectives of this study were to design and test a new measure of both positive and negative moods in individuals aged 55 years or older with mild to severe AD-RD.
METHODS: Formal and informal caregivers' observations of mood in this population generated 26 positive and 27 negative mood descriptors reviewed by content experts before pilot testing. The AD-RD Mood Scale and Mini-Mental State Examination were administered to 298 participants with very mild to severe cognitive impairment. Two examiners simultaneously rated a subsample of participants, a second subsample was retested after 2 weeks, and additional mood measures were administered to a third subsample.
RESULTS: The final AD-RD Mood Scale contains 34 items in two positive subscales (spirited and contented) and three negative subscales (hostile, apathetic, and sad). The five subscales explain 82% of the variance. Cronbach's alpha values were .92, .90, .85, .77, and .73 for the spirited, hostile, contented, apathetic, and sad subscales, respectively. Interrater reliability ranged from .88 to .63. Mean subscale scores were stable over time. Moderate to strong validity coefficients (Pearson's r) produced by comparison with four existing measures were in the hypothesized direction. Subscale scores discriminated between participants who are depressed and those who are nondepressed. DISCUSSION: The final 34-item AD-RD Mood Scale provides useful data on both positive and negative moods of individuals with AD-RD. Further evaluation of reliability and validity in a multiethnic sample is recommended, as are confirmatory factor analysis and expansion to add subscales related to tension and social unease.

Entities:  

Mesh:

Year:  2008        PMID: 19018217      PMCID: PMC2667280          DOI: 10.1097/NNR.0b013e31818c3dcc

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  29 in total

1.  Emotional well-being predicts subsequent functional independence and survival.

Authors:  G V Ostir; K S Markides; S A Black; J S Goodwin
Journal:  J Am Geriatr Soc       Date:  2000-05       Impact factor: 5.562

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Quality of life in patients with Alzheimer's disease as reported by patient proxies.

Authors:  S M Albert; C Del Castillo-Castaneda; M Sano; D M Jacobs; K Marder; K Bell; F Bylsma; G Lafleche; J Brandt; M Albert; Y Stern
Journal:  J Am Geriatr Soc       Date:  1996-11       Impact factor: 5.562

4.  Emotional well-being in a person with dementia.

Authors:  Ann M Kolanowski; Mark S Litaker; Patricia A Catalano
Journal:  West J Nurs Res       Date:  2002-02       Impact factor: 1.967

5.  Qualitative and quantitative measurement of depression in veterans recovering from stroke.

Authors:  Christine L Williams; Maude R Rittman; Craig Boylstein; Christopher Faircloth; Qin Haijing
Journal:  J Rehabil Res Dev       Date:  2005 May-Jun

6.  Depressive symptoms, depletion, or developmental change? Withdrawal, apathy, and lack of vigor in the Geriatric Depression Scale.

Authors:  K B Adams
Journal:  Gerontologist       Date:  2001-12

7.  Assessment of affect in advanced Alzheimer's disease: the Dementia Mood Picture Test.

Authors:  R M Tappen; C Barry
Journal:  J Gerontol Nurs       Date:  1995-03       Impact factor: 1.254

8.  Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS.

Authors:  Lawrence S Mayer; R Curt Bay; Antonios Politis; Martin Steinberg; Cynthia Steele; Alva S Baker; Peter V Rabins; Constantine G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2006-10       Impact factor: 3.485

Review 9.  Screening accuracy for late-life depression in primary care: a systematic review.

Authors:  Lea C Watson; Michael P Pignone
Journal:  J Fam Pract       Date:  2003-12       Impact factor: 0.493

10.  Losing one's memory in early Alzheimer's disease.

Authors:  Karen Parsons-Suhl; Mary E Johnson; Judy J McCann; Shirley Solberg
Journal:  Qual Health Res       Date:  2008-01
View more
  6 in total

1.  Validation of Pictorial Mood Assessment with Ottawa Mood Scales and the Positive and Negative Affect Scale for Young Adults.

Authors:  Mei-Yi Wong; Paul E Croarkin; Chen Kang Lee; Poh Foong Lee
Journal:  Community Ment Health J       Date:  2020-07-13

2.  Improving Behavioral and Psychological Symptoms and Cognitive Status of Participants with Dementia Through the Use of Therapeutic Interactive Pets.

Authors:  Bryanna Streit LaRose; Lisa Kirk Wiese; María de Los Ángeles Ortega Hernández
Journal:  Issues Ment Health Nurs       Date:  2021-10-13       Impact factor: 1.790

Review 3.  Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.

Authors:  Vasiliki Orgeta; Phuong Leung; Rafael Del-Pino-Casado; Afifa Qazi; Martin Orrell; Aimee E Spector; Abigail M Methley
Journal:  Cochrane Database Syst Rev       Date:  2022-04-25

Review 4.  Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.

Authors:  Vasiliki Orgeta; Afifa Qazi; Aimee E Spector; Martin Orrell
Journal:  Cochrane Database Syst Rev       Date:  2014-01-22

5.  Memory matters in dementia: Efficacy of a mobile reminiscing therapy app.

Authors:  Fang Yu; Michelle A Mathiason; Kari Johnson; Joseph E Gaugler; Dan Klassen
Journal:  Alzheimers Dement (N Y)       Date:  2019-10-23

6.  Effects of aerobic exercise on cognition and hippocampal volume in Alzheimer's disease: study protocol of a randomized controlled trial (The FIT-AD trial).

Authors:  Fang Yu; Ulf G Bronas; Suma Konety; Nathaniel W Nelson; Maurice Dysken; Clifford Jack; Jean F Wyman; David Vock; Glenn Smith
Journal:  Trials       Date:  2014-10-11       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.